Who
David Angelo Lazzarato
Director
Company insider
Files Form 4 as: Chief Accounting Officer, Canopy Growth.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $371K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jun 2020
- Last trade
- 28 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 30 Sep 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $21K22,380 at $0.9268 | filing |
| 28 Sep 2026filed 30 Sep 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $21K22,380 at $0.93 | filing |
| 26 Jun 2026filed 29 Jun 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $21K22,674 at $0.9237 | filing |
| 26 Jun 2026filed 29 Jun 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $21K22,674 at $0.92 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Code A | —162,485 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Code A | —162,485 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $15K15,624 at $0.93 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $15K15,624 at $0.93 | filing |
| 31 Dec 2025filed 2 Jan 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $18K15,715 at $1.13 | filing |
| 31 Dec 2025filed 2 Jan 2026 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $18K15,715 at $1.13 | filing |
| 29 Sep 2025filed 30 Sep 2025 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $25K15,677 at $1.58 | filing |
| 30 Jun 2025filed 2 Jul 2025 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $19K15,701 at $1.23 | filing |
| 3 Jun 2025filed 5 Jun 2025 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Code A | —111,879 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $2,7643,004 at $0.92 | filing |
| 31 Dec 2024filed 3 Jan 2025 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $8,0263,006 at $2.67 | filing |
| 30 Sep 2024filed 2 Oct 2024 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $15K2,993 at $4.95 | filing |
| 28 Jun 2024filed 2 Jul 2024 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $19K2,986 at $6.41 | filing |
| 10 Jun 2024filed 12 Jun 2024 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Code A | —21,540 at $0.00 | filing |
| 10 Jun 2024filed 12 Jun 2024 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $37K3,707 at $9.94 | filing |
| 29 Dec 2023filed 2 Jan 2024 | CGC Canopy GrowthPharmaceuticals | SEC FORM 4 Sold | $25K3,713 at $6.68 | filing |
News
Canopy Growth (TSE:WEED) Hits New 12-Month Low – What's Next?CGC · dailypolitical.com · 20 Oct 2026Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.CGC · fool.com · 18 Oct 2026Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?CGC · fool.com · 15 Oct 2026
0 headlines in the last 90 days name David Angelo Lazzarato; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.